Insider Transactions Reported by 6 Insiders of OKYO Pharma Ltd

Symbol
OKYO on Nasdaq
Location
London, United Kingdom

There are no Buy or Sell transactions made by insiders since 21 Jan 2025

OKYO Pharma Ltd executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gabriele M. Cerrone Executive Chairman, Director $13,766,855 23 Oct 2023
Gary Jacob Chief Executive Officer, Director $50,000 19 May 2022
John Brancaccio Director $25,005 15 Sep 2023
Bernard Denoyer Director 16 May 2022
Willy Jules Simon Director 16 May 2022
Keeren Shah Chief Financial Officer 16 May 2022

Recent Insider Transactions by Companies or Individuals for OKYO Pharma Ltd

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.